← FDA DRUG APPROVALS
FDA ANDA · ANDA090619
IBUPROFEN AND DIPHENHYDRAMINE CITRATE
Sponsor: DR REDDYS LABS LTD
APPLICATION
ANDA090619
TYPE
ANDA
ORIGINAL APPROVAL
2009-07-08
LATEST ACTION
2015-01-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter
Products
IBUPROFEN AND DIPHENHYDRAMINE CITRATEOver-the-counter
DIPHENHYDRAMINE CITRATE 38MG, IBUPROFEN 200MG · TABLET · ORAL
Approval history
2015-01-20Labeling · Supplement 3AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.